(Q34251176)

31 July 2017

title

The SSRIs: advantages, disadvantages and differences (English)

1 reference

31 July 2017

R Lane

1

1 reference

31 July 2017

D Baldwin

series ordinal

2

1 reference

31 July 2017

S Preskorn

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

Journal of Psychopharmacology

31 July 2017

published in

1 reference

31 July 2017

volume

9

1 reference

31 July 2017

issue

2 Suppl

1 reference

31 July 2017

page(s)

163-178

1 reference

Possible interaction between fluoxetine and pimozide causing sinus bradycardia

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Fluoxetine, fluvoxamine and extrapyramidal tract disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Rapid down regulation of beta-adrenoceptors by co-administration of desipramine and fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Weight gain. A side-effect of tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

The Association of Age and Depression Among the Elderly: An Epidemiologic Exploration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Comparative animal studies on cardiovascular toxicity of tri- and tetracyclic antidepressants and citalopram; relation to drug plasma levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Fluoxetine and norfluoxetine are potent inhibitors of P450IID6--the source of the sparteine/debrisoquine oxidation polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Fluoxetine in elderly patients: is there cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Suicide and attempted suicide in general practice, 1979-1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Withdrawal phenomena associated with antidepressant and antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

EEG lateral asymmetries in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

A comparison of paroxetine and placebo in depressed outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Stereoselective drug disposition: potential for misinterpretation of drug disposition data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Clinical predictors of suicide in patients with major affective disorders: a controlled prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Why do some antidepressants promote suicide?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Interaction between carbamazepine and fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Managing depression in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Possible adverse drug interactions between fluoxetine and other psychotropics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

A case of fluoxetine-induced serum sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Prophylactic treatment of depression: a public health issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Reduced mortality of manic-depressive patients in long-term lithium treatment: an international collaborative study by IGSLI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Serotonin syndrome produced by a combination of fluoxetine and lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Preliminary studies of the kinetics of citalopram in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Recognition and management of depression in general practice: consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Psychotropic drug use and the risk of hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Psychiatric Malpractice: A Regional Incidence Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Toxic Interaction Between Fluvoxamine and Sustained Release Theophylline in an 11-Year-Old Boy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

21 January 2018

The serotonin syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Drugs, dry mouth, and dental disease. A case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

The economic burden of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Clinical pharmacokinetics of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Affective disorders in a US urban community: the use of research diagnostic criteria in an epidemiological survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Fluoxetine-warfarin interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

The pharmacokinetics of paroxetine in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881195009002011

10.1177/0269881195009002011

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference